The high mobility group A1 gene: transforming inflammatory signals into cancer?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20068164.
- Also identified by DOI 10.1158/0008-5472.CAN-09-1212 and PMC identifier 2807996.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High mobility group A1 (HMGA1) is highly expressed during embryogenesis and in poorly differentiated cancers, and high levels portend a poor prognosis in some tumors. HMGA1 induces oncogenic transformation in cultured cells and causes aggressive cancers in transgenic mice, whereas blocking it interferes with transformation in experimental models. These findings suggest a pivotal role for HMGA1 in cancer. This review focuses on two recently described HMGA1 transcriptional targets that mediate inflammatory signals and drive malignant transformation because they could serve as biomarkers or therapeutic targets. Further elucidation of HMGA1 function in transformation promises to have a major impact on our war on cancer.
Medical subject headings
- Cell Transformation, Neoplastic
- HMGA1a Protein